X4 Pharmaceuticals, Inc - Common Stock (XFOR)

CUSIP: 98420X202

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / Common Stock
Shares outstanding
87,101,353
Total 13F shares
13,652,105
Share change
+11,501,554
Total reported value
$46,690,414
Price per share
$3.42
Number of holders
40
Value change
+$40,048,768
Number of buys
20
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP 98420X202?
CUSIP 98420X202 identifies XFOR - X4 Pharmaceuticals, Inc - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of X4 Pharmaceuticals, Inc - Common Stock (XFOR) as of Q3 2025

As of 30 Sep 2025, X4 Pharmaceuticals, Inc - Common Stock (XFOR) was held by 40 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,652,105 shares. The largest 10 holders included Bain Capital Life Sciences Investors, LLC, BVF INC/IL, Nantahala Capital Management, LLC, Rosalind Advisors, Inc., Deep Track Capital, LP, Stonepine Capital Management, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., STEMPOINT CAPITAL LP, VANGUARD GROUP INC, and BOOTHBAY FUND MANAGEMENT, LLC. This page lists 40 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.